Back to Search
MICHAEL PANZARA, MD
MD
Neurology Physician
NPI: 1790766145Individual
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
152373(MA)
Research & Publications (20)
Evaluating human T cell receptor gene expression by PCR.
PMID 18432691·Curr Protoc Immunol·2001
6-review
Assessing disability progression with the Multiple Sclerosis Functional Composite.
PMID 19667023·Mult Scler·2009
8-other
GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study.
PMID 19255407·Neurology·2009
3-trial
Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a.
PMID 19506220·Neurology·2009
3-trial
Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function.
PMID 19188571·Neurology·2009
3-trial
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL.
PMID 19308305·J Neurol·2009
2-rct
Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.
PMID 18573822·Mult Scler·2008
4-observational
Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.
PMID 18383069·Ann Neurol·2008
3-trial
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
PMID 18272891·N Engl J Med·2008
3-trial
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS.
PMID 17452584·Neurology·2007
3-trial
A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis.
PMID 17277910·J Neurol·2007
4-observational
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis.
PMID 17438220·Neurology·2007
3-trial
Health-related quality of life in multiple sclerosis: effects of natalizumab.
PMID 17696126·Ann Neurol·2007
2-rct
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL.
PMID 17761550·Neurology·2007
2-rct
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
PMID 16510745·N Engl J Med·2006
3-trial
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
PMID 16510744·N Engl J Med·2006
3-trial
Infusion-related hypersensitivity reactions during natalizumab treatment.
PMID 17101921·Neurology·2006
5-case
Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis.
PMID 16193895·Mult Scler·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 15 PARKMAN ST, WAC 835
BOSTON, MA 02114 - Phone
- (617) 726-7643
Quick Facts
- NPI
- 1790766145
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile